Related Experiment Video

Updated: Jan 24, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

1.5K

FFNT25 ameliorates unilateral ureteral obstruction-induced renal fibrosis

Wen Li1, Yue Lu1, Yan Lou1

  • 1a Department of Nephropathy , The Second Hospital of Jilin University , Changchun , China.

Renal Failure
|May 30, 2019
PubMed

Insights

FFNT25 effectively reduces renal fibrosis in rats with chronic kidney disease. This molecular compound impacts collagen production and degradation, offering a potential new therapy for kidney fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pharmacology

Background:

  • Renal fibrosis is a key factor in chronic kidney disease (CKD) progression to end-stage renal disease (ESRD).
  • Developing effective anti-fibrotic therapies is crucial due to the rising incidence of CKD.

Purpose of the Study:

  • To investigate the anti-fibrosis mechanism of FFNT25 in a rat model of kidney injury.
  • To evaluate FFNT25's effect on extracellular matrix deposition and collagen remodeling.

Main Methods:

  • Unilateral ureteral obstruction (UUO) model in Sprague-Dawley rats.
  • Administration of FFNT25 (20.6 mg/kg/day) or vehicle for two weeks post-UUO.
  • Analysis of renal fibrosis markers, including alpha-smooth muscle actin (α-SMA) and plasminogen activator inhibitor-1 (PAI-1) at mRNA and protein levels.

Main Results:

  • FFNT25 treatment significantly reduced renal fibrosis markers compared to vehicle control.
  • Decreased mRNA and protein expression of extracellular matrix (ECM) components α-SMA and PAI-1 was observed.
  • FFNT25 demonstrated an ability to modulate both collagen production and degradation pathways.

Conclusions:

  • FFNT25 exhibits significant anti-fibrotic properties in a UUO-induced kidney injury model.
  • The compound's mechanism involves regulating extracellular matrix turnover, suggesting therapeutic potential for renal fibrosis.
Keywords:
FFNT25PAI-1UUOrenal fibrosisα-SMA

More Related Videos

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction06:37

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction

Published on: April 4, 2025

806
A Murine Model of Irreversible and Reversible Unilateral Ureteric Obstruction14:05

A Murine Model of Irreversible and Reversible Unilateral Ureteric Obstruction

Published on: December 20, 2014

32.1K

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
743
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
436
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
7.1K
Renal Clearance01:23

Renal Clearance

The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
2.5K
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
580
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
489